Ozempic and Wegovy have received a lot of publicity as revolutionizing treatment options for obesity. Both medications form a class of GLP-1 receptor agonists, which mimic a hormone in the body called glucagon-like peptide-1 and are involved in the regulation of appetite and blood sugar. Indeed, in initial clinical studies, the majority of those on the drugs lost 15% to 22% of body weight, hence much optimism. For most patients, these medications are underwhelming for about 20% of patients due to minimal weight loss or other challenges.

Take a closer look at why the weight loss drugs may not work for everyone, together with what options exist when they don't deliver the expected outcomes.

Why Weight Loss Drugs May Not Work

While GLP-1 receptor agonists have produced phenomenal responses in a majority of patients, it remains a reality that these drugs work differently for different people. Here's why:

1. Genetic and Hormonal Variability

Weight loss medications interact with complex systems in the body that differ from person to person. Genetics, hormones, and individual brain responses to energy regulation play significant roles in determining how a person responds to drugs like Ozempic and Wegovy.

2. Underlying Medical Conditions

Other conditions, such as sleep apnea, may be prevalent and prevent or delay the achievement of weight loss goals. Prescription drugs like antidepressants, steroids, or contraceptives are other medications that can nullify weight loss medication benefits.

3. Unrealistic Expectations

Often, they come to these medications with enormous hopes; expecting the promised rapid and dramatic weight loss. Progress creates disappointment if it has not stalled. In patients who rigidly follow recommended lifestyle modifications, frustration and disappointment are most common.

Why it is Important to Identify Non-responders

For most patients, the effectiveness of GLP-1 receptor agonists is evident within a few weeks of treatment. Weight loss typically begins within a few weeks of initiating therapy and tends to increase with dosage. However, some patients respond very little, if at all, despite strict adherence to their regimen.

For nonresponders, this can feel like a dead end. However, understanding the unique complexities of obesity is essential. This condition stems from brain dysfunction, and the pathways that contribute to weight regulation differ among individuals.

Alternative Treatment Options

When Ozempic or Wegovy doesn’t yield desired results, there are still many paths to explore:

1. Switching to Another GLP-1 Drug

For example, some patients who don't respond well to one GLP-1 receptor agonist might find success with another drug in the same class. Newer medications, such as Zepbound, target other hormone pathways and seem promising even for those not responsive to earlier drugs.

2. Use of Older Medications

While there is much to say about newer drugs, older treatments can still be useful and work for some patients. One can also seek the help of a medical provider specializing in obesity treatments in order to identify the best alternatives.

3. Lifestyle Changes

Diet, exercise, sleep, and stress management continue to be integral components of any weight loss program. New changes may be small but can make an enormous difference in one's health and success.

4. Medical Management of Obesity

It is a complex disorder, and most patients should receive a multidisciplinary treatment. Collaboration with an obesity-aware doctor may mean access to tailored treatment plans, ranging from psychological support all the way to metabolic testing, and many others.

Why Side Effects of Weight Loss Drug Ozempic May Be a Barrier

For others, side effects like nausea, vomiting, or diarrhea hinder them from continuing with these drugs. These symptoms often reduce as the body becomes accustomed, but for some, they might be severe enough to stop treatment altogether. In those instances, alternative drugs or procedures become vital to find.

Long-term effects of Ozempic or Wegovy on the Brain

Another largely unexplored area relates to GLP-1 drugs' long-term effects on the brain's regulation of hunger and satiety. Although GLP-1 drugs suppress appetite and can lead to effective weight loss, emerging research suggests that they may also affect brain reward mechanisms, changing the way patients experience foods.

This aspect could prove of paramount significance in the future treatment of obesity. Perhaps GLP-1 receptor agonists do indeed affect and rewire the brain's reward pathways and will thus provide sustained benefits beyond discontinuation. However, more research is required to understand this phenomenon fully.

While for many, Ozempic and Wegovy have revolutionized obesity treatment, these are certainly not a one size fits all. Nonresponders need not lose hope- alternative strategies and medications abound. A consultation with an obesity expert healthcare provider is essential to put together a comprehensive, tailored treatment plan.

The route toward effective weight loss may be challenging, but with the evolution of obesity medicine and a better understanding of individual needs, there is a path forward for everyone.

Living under constant psychosocial stress can significantly raise the risk of developing dementia and a stroke, a JAMA Network study suggests.

Psychosocial stress is a type of stress related to our relationships with others, usually arising from feeling judged, excluded, or not enough in others' eyes. It can also put a person in fight-or-flight mode, causing both mental and physical symptoms.

According to Chinese researchers, people who experience this form of stress in childhood as well as adulthood face more than a threefold higher risk of developing dementia compared with those in other groups.

Similarly, young people experiencing stressful situations in their adulthood had a significantly higher risk of stroke incidence that their counterparts.

Based on these results, the study highlights that early identification of psychosocial stressors, combined with effective mental health support and depression prevention, may reduce the long-term burden of neurodegenerative and cerebrovascular disease.

What Did The Study Find?

The scientists defined adverse childhood experiences (ACEs) as traumatic exposures occurring during childhood, typically grouped into 3 categories: household dysfunction, social dysfunction and family death or disability.

On the other hand, traumatic exposures occurring during adulthood were defined as adverse adult experiences (AAEs), which include events such as the death of a child, lifetime discrimination, ever being confined to bed, ever being hospitalized for a month or longer and ever leaving a job due to health conditions.

While analyzing the data they collected from the participants, the researchers also found that depression partly explained the links in all major relationships as it accounted for more than one-third of the connection between childhood adversity and dementia, and about one-fifth of the link between adulthood adversity and both dementia and stroke.

READ MORE: Avoid Doing These 3 Things Prevent Dementia, According To Neurologist

These findings suggest that long-term psychological stress may lead to brain and blood vessel diseases by causing ongoing emotional distress, unhealthy behaviours, and biological changes like inflammation and abnormal stress responses.

Psychosocial Stress: An Unseen Form Of Stress

Psychosocial stress can trigger physiological responses like increased heart rate, cortisol secretion, and inflammation, significantly increasing risks for hypertension, cardiovascular disease and mental health disorders.

This kind of stress can affect men, women, and people of all genders differently, but many of the symptoms are still the same. Common symptoms include:

• Sweating
• An increase in blood pressure
• Rapid heartbeat
• Dizziness
• Nausea and digestive problems
• Strong emotional reactions such as sadness or irritability
• Drug or alcohol abuse

These symptoms can be acute or chronic, meaning for some people they go away, and for others, they persist over a long period of time. Meeting with a therapist is often recommended for those living with chronic stress.

Experts typically suggest developing coping mechanisms include building support networks, utilizing relaxation techniques, and, in cases of severe mental impact, seeking professional support to help deal with psychosocial stress.

Cardiovascular disease remains the leading cause of death among women, claiming more lives each year than all cancers combined. Yet, it continues to be misunderstood, underdiagnosed, and often dismissed as a “male” health problem. In Ohio and across the US, women are now using a striking visual message to confront this reality head-on, by quite literally dressing for the cause.

February, observed as American Heart Month, marks a renewed push to educate communities about heart disease, especially among women. Health advocates stress that while the spotlight is brightest this month, the risks and responsibilities extend far beyond the calendar.

“It’s our Super Bowl,” said Lauren Thomas, development director for the American Heart Association of North Central West Virginia and Ohio Valley. “It’s about awareness. Heart health is not a one-month conversation. It has to be a year-round priority where people actively put their hearts first.”

Why Red Has Become a Warning Sign

Across Ohio, women are wearing red, a color long associated with love but also with danger. The message is deliberate. Red symbolizes the urgency of cardiovascular disease, a condition responsible for one in every three deaths among women.

“When we wear red, we start conversations that many people avoid,” said Melissa Pratt, a heart disease survivor, reported WBBJ News. “One in three women die from cardiovascular disease. Wearing red encourages women to get checked, understand their risks, and take their health seriously.”

From landmarks lit in red to workplaces, neighborhoods, and social media feeds filled with crimson outfits, the visual campaign is meant to disrupt complacency. It asks a confronting question. If heart disease is killing women at this scale, why is it still not treated like a crisis?

Ohio Valley And Downtown Jackson Women Taking the Lead

Coinciding with American Heart Month, the Ohio Valley Women of Impact campaign launches this Friday. Six local women, Crissy Clutter, Jan Pattishall-Krupinski, Lacy Ferguson, Shelbie Smith, Jennifer Hall-Fawson, and Laurie Conway, are leading fundraising and awareness efforts aimed at improving women’s heart health.

Their work focuses on education, early detection, and supporting research that better understands how heart disease presents differently in women. Symptoms in women can be subtle, ranging from fatigue and nausea to jaw or back pain, which often delays diagnosis and treatment.

Turning Awareness Into Action

To mark the start of the month, the American Heart Association hosted a National Wear Red Day breakfast on Friday morning at the LIFT Wellness Center in Jackson Walk Plaza. The event brought together survivors, advocates, and health professionals to reinforce a simple but powerful message. Awareness must lead to action.

Health experts continue to urge women to prioritize regular checkups, manage blood pressure, cholesterol, and stress, and recognize early warning signs. Lifestyle changes, timely screenings, and informed conversations can significantly reduce risk.

Dressed In Death, Fighting For Life

The women of Ohio are not wearing red for fashion. They are wearing it as a warning, a remembrance, and a call to action. In dressing themselves in the color of urgency, they are confronting a disease that has taken too many lives quietly. This February, their message is clear. Heart disease is not inevitable, but ignoring it can be deadly.

If your roots trace back to the Indian subcontinent, your risk of developing type 2 diabetes is significantly higher than that of Europeans. Research shows that Indians, Pakistanis, and Bangladeshis are up to six times more likely to develop the condition, often at a younger age and at lower body weights. For years, carbohydrate-heavy diets were blamed. But growing scientific evidence points to a far deeper and darker cause: repeated famines during British colonial rule that may have altered metabolic resilience across generations.

Can Hunger Change Human Biology?

The idea that starvation can leave a genetic imprint may sound extreme, but science supports it. Prolonged nutrient deprivation can permanently affect how the body stores fat, processes glucose, and responds to food abundance later in life. Even a single famine can raise the risk of metabolic disorders such as diabetes in future generations.

This understanding forms the basis of the “thrifty genotype hypothesis,” a concept widely discussed in evolutionary biology.

The Thrifty Genotype Hypothesis Explained

The thrifty genotype hypothesis suggests that populations exposed to repeated famines develop genetic traits that help conserve energy. These traits are lifesaving during scarcity but become harmful in times of plenty, increasing the risk of obesity and diabetes.

Economic historian Mike Davis documents that India experienced 31 major famines during 190 years of British rule between 1757 and 1947, roughly one every six years. By contrast, only 17 famines occurred in the previous 2,000 years. Davis estimates that 29 million people died in the Victorian era alone. Economic anthropologist Jason Hickel places the death toll from colonial policies between 1880 and 1920 at around 100 million.

Scientific Evidence Linking Famines to Diabetes

A study published in Frontiers in Public Health titled The Elevated Susceptibility to Diabetes in India: An Evolutionary Perspective argues that these famines reshaped metabolic traits. The researchers note that Indians tend to have a higher fat-to-lean mass ratio, lower average birth weight, and reduced ability to clear glucose. This combination increases metabolic stress and lowers resilience, explaining earlier onset of diabetes compared to Europeans.

A Nation That Shrunk Over Time

Colonial-era famines also affected physical growth. Studies show that average Indian height declined by about 1.8 cm per century during British rule. Historian accounts describe ancient Indians as tall and robust, with even Greek chroniclers noting their stature during Alexander’s invasion. By the 1960s, however, Indians were about 15 cm shorter than their Mesolithic ancestors.

Read: How Colonialism Continues To Bear An Impact On The South Asian Health Crisis

While the British did not cause early declines, widespread impoverishment under colonial rule sharply accelerated the trend. Only in the past 50 years has average height begun to recover.

Famines Were Policy Failures, Not Nature

Mike Davis argues that colonial famines were driven not by food shortages but by policy. Grain continued to be exported even as millions starved. During the 1876 famine, Viceroy Robert Bulwer-Lytton refused to halt exports, and relief work was deliberately discouraged. Davis describes these deaths as the result of state policy, not natural disaster.

Medical journal The Lancet estimated that 19 million Indians died during famines in the 1890s alone.

Breaking the Diabetes Cycle

India now faces the consequences. According to the Indian Council of Medical Research, over 101 million Indians live with diabetes today. Experts argue that prevention must begin early, with reduced sugar intake, low-glycaemic diets, healthier fats, and compulsory physical activity in schools. Education about famine-linked intergenerational health risks could also help younger generations make informed choices.

India has avoided famine since Independence in 1947. The next challenge is ensuring that history’s biological scars do not continue to shape its future.